A comprehensive review of rituximab therapy in rheumatoid arthritis patients.
Tavakolpour S, Alesaeidi S, Darvishi M, GhasemiAdl M, Darabi-Monadi S, Akhlaghdoust M, Elikaei Behjati S, Jafarieh A.
Tavakolpour S, et al.
Clin Rheumatol. 2019 Nov;38(11):2977-2994. doi: 10.1007/s10067-019-04699-8. Epub 2019 Aug 1.
Clin Rheumatol. 2019.
PMID: 31367943
Review.
Lower exposure to other biologics, presence of some serological markers (e.g., anti-RF, anti-CCP, IL-33, ESR), specific variations in FCGR3A, FCGR2A, TGFbeta1, IL6, IRF5, BAFF genes, and also EBV-positivity could be used to predict response to RTX. ...
Lower exposure to other biologics, presence of some serological markers (e.g., anti-RF, anti-CCP, IL-33, ESR), specific variations in …